Oncoplastic Surgery with Volume Replacement versus Mastectomy with Implant-Based Breast Reconstruction: Early Postoperative Complications in Patients with Breast Cancer

Abstract

Background Two common surgical approaches for breast cancer are breast-conserving surgery and mastectomy with implant-based breast reconstruction (MIBR). However, for large tumors, an alternative to MIBR is oncoplastic surgery with volume replacement (OPSVR). We performed a comprehensive analysis comparing OPSVR with MIBR, with our aim to focus on the 30-day postoperative complications between these two techniques.

Methods We conducted a retrospective cohort study using the National Surgical Quality Improvement Program (NSQIP) database from 2005 to 2020. Only breast cancer patients were included and were divided according to the surgical technique: OPSVR and MIBR. Logistic regression analysis was used to assess independent risk factors for total, surgical, and wound complications.

Results A cohort of 8,403 breast cancer patients was analyzed. A total of 683 underwent OPSVR and 7,720 underwent MIBR. From 2005 to 2020, the adoption of OPSVR gradually increased over the years (p < 0.001), whereas MIBR decreased. OPSVR patients were older (57.04 vs. 51.89 years, p < 0.001), exhibited a higher body mass index (31.73 vs. 26.93, p < 0.001), had a greater prevalence of diabetes mellitus (11.0 vs. 5.0%, p < 0.001). They also had a higher ASA classification (2.33 vs. 2.15, p < 0.001), shorter operative time (173.39 vs. 216.20 minutes, p < 0.001), and a higher proportion of outpatient procedures (83.7 vs. 39.5%, p < 0.001). Outcome analysis demonstrated fewer total complications in the OPSVR patients (4.2 vs. 10.9%, p < 0.001), including lower rates of surgical complications (2.2 vs. 8.0%, p < 0.001) and wound complications (1.9 vs. 4.8%, p = 0.005) compared with MIBR patients. Multivariate analysis identified OPSVR as an independent protective factor for total, surgical, and wound complications.

Conclusion OPSVR has become a favorable technique for patients with breast cancer. Even in patients with higher comorbidities, OPSVR demonstrates safe and better outcomes when compared with MIBR. It should be considered a reasonable and safe breast surgical option in the appropriate patient.

Keywords

oncoplastic surgery - mastectomy implant-based reconstruction - outcomes - complications

Data Availability Statement

The data that support the findings of this study are available upon request at the American College of Surgeons National Surgical Quality Improvement Program.

Note

This work was presented at the 25^th Annual Meeting of the American Society of Breast Surgeons, Orlando, FL, April 2024.

Publikationsverlauf

Eingereicht: 21. Juli 2024

Angenommen: 23. November 2024

Accepted Manuscript online:
28. November 2024

Artikel online veröffentlicht:
20. Dezember 2024

• References

• 1 André C, Holsti C, Svenner A. et al. Recurrence and survival after standard versus oncoplastic breast-conserving surgery for breast cancer. BJS Open 2021; 5 (01) zraa013
• 2 Nardello SM, Bloom JA, Gaffney KA, Singhal M, Persing S, Chatterjee A. Practical oncoplastic surgery techniques needed for practice. Ann Transl Med 2023; 11 (11) 383
• 3 Campbell EJ, Romics L. Oncological safety and cosmetic outcomes in oncoplastic breast conservation surgery, a review of the best level of evidence literature. Breast Cancer (Dove Med Press) 2017; 9: 521-530
• 4 Chatterjee A, Gass J, Patel K. et al. A consensus definition and classification system of oncoplastic surgery developed by the American Society of Breast Surgeons. Ann Surg Oncol 2019; 26 (11) 3436-3444
• 5 Margenthaler JA, Dietz JR, Chatterjee A. The landmark series: breast conservation trials (including oncoplastic breast surgery). Ann Surg Oncol 2021; 28 (04) 2120-2127
• 6 Losken A, Chatterjee A. Improving results in oncoplastic surgery. Plast Reconstr Surg 2021; 147 (01) 123e-134e
• 7 Nanda A, Hu J, Hodgkinson S, Ali S, Rainsbury R, Roy PG. Oncoplastic breast-conserving surgery for women with primary breast cancer. Cochrane Database Syst Rev 2021; 10 (10) CD013658
• 8 Rose M, Svensson H, Handler J, Hoyer U, Ringberg A, Manjer J. Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer. Breast Cancer Res Treat 2020; 180 (01) 247-256
• 9 Crown A, Scovel LG, Rocha FG, Scott EJ, Wechter DG, Grumley JW. Oncoplastic breast conserving surgery is associated with a lower rate of surgical site complications compared to standard breast conserving surgery. Am J Surg 2019; 217 (01) 138-141
• 10 Oberhauser I, Zeindler J, Ritter M. et al. Impact of oncoplastic breast surgery on rate of complications, time to adjuvant treatment, and risk of recurrence. Breast Care (Basel) 2021; 16 (05) 452-460
• 11 Babu P, Chidananda Murthy G. Oncoplastic breast surgery: a single-institution experience. Indian J Surg Oncol 2023; 14 (01) 199-203
• 12 Xu Y, Cao J, Gong K. et al. Oncoplastic breast-conserving surgery improves cosmetic outcomes without increasing recurrence risk compared to modified radical mastectomy in early breast cancer patients: development and validation of a recurrence risk prediction model. Am J Cancer Res 2023; 13 (09) 4259-4268
• 13 Patel K, Bloom J, Nardello S, Cohen S, Reiland J, Chatterjee A. An oncoplastic surgery primer: common indications, techniques, and complications in level 1 and 2 volume displacement oncoplastic surgery. Ann Surg Oncol 2019; 26 (10) 3063-3070
• 14 Char S, Bloom JA, Erlichman Z, Jonczyk MM, Chatterjee A. A comprehensive literature review of patient-reported outcome measures (PROMs) among common breast reconstruction options: what types of breast reconstruction score well?. Breast J 2021; 27 (04) 322-329
• 15 Losken A, Dugal CS, Styblo TM, Carlson GW. A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique. Ann Plast Surg 2014; 72 (02) 145-149
• 16 Pawlak N, Karamchandani M, Wareham C. et al. Comparing oncoplastic breast reduction with immediate symmetry surgery to standard breast reduction surgery: are postoperative complications worse?. J Surg Oncol 2022; 126 (06) 956-961
• 17 Schaverien MV, Kuerer HM, Caudle AS, Smith BD, Hwang RF, Robb GL. Outcomes of volume replacement oncoplastic breast-conserving surgery using chest wall perforator flaps: comparison with volume displacement oncoplastic surgery and total breast reconstruction. Plast Reconstr Surg 2020; 146 (01) 14-27
• 18 Noguchi M, Yokoi-Noguchi M, Ohno Y. et al. Oncoplastic breast conserving surgery: volume replacement vs. volume displacement. Eur J Surg Oncol 2016; 42 (07) 926-934
• 19 Rutherford CL, Barker S, Romics L. A systematic review of oncoplastic volume replacement breast surgery: oncological safety and cosmetic outcome. Ann R Coll Surg Engl 2022; 104 (01) 5-17
• 20 National Cancer Institute. Surveillance, Epidemiology, and End Results. Cancer Stat Facts: Cancer Stat Facts: Female Breast Cancer. Accessed September 8, 2024 at: https://seer.cancer.gov/statfacts/html/breast.html
• 21 Xu S, Murtagh S, Han Y, Wan F, Toriola AT. Breast cancer incidence among US women aged 20 to 49 years by race, stage, and hormone receptor status. JAMA Netw Open 2024; 7 (01) e2353331
• 22 van der Wielen A, Negenborn V, Burchell GL, Remmelzwaal S, Lapid O, Driessen C. Less is more? One-stage versus two-stage implant-based breast reconstruction: a systematic review and meta-analysis of comparative studies. J Plast Reconstr Aesthet Surg 2023; 86: 109-127
• 23 Jagsi R, Jiang J, Momoh AO. et al. Complications after mastectomy and immediate breast reconstruction for breast cancer: a claims-based analysis. Ann Surg 2016; 263 (02) 219-227
• 24 Potter S, Conroy EJ, Cutress RI. et al; iBRA Steering Group, Breast Reconstruction Research Collaborative. Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study. Lancet Oncol 2019; 20 (02) 254-266
• 25 Rainsbury D, Willett A. Oncoplastic breast reconstruction: guidelines for best practice: ABS and BAPRAS, 2012. Accessed September 8, 2024 at: http://www.bapras.org.uk/docs/default-source/commissioning-and-policy/final-oncoplastic-guidelines-healthcare-professionals.pdf?sfvrsn=0
• 26 Ryu H, Shin KH, Chang JH, Jang B-S. A nationwide study of breast reconstruction after mastectomy in patients with breast cancer receiving postmastectomy radiotherapy: comparison of complications according to radiotherapy fractionation and reconstruction procedures. Br J Cancer 2024; 131 (02) 290-298
• 27 Mak JCK, Kwong A. Complications in post-mastectomy immediate breast reconstruction: a ten-year analysis of outcomes. Clin Breast Cancer 2020; 20 (05) 402-407
• 28 Benedict KC, Brown MI, Berry HA, Berry SM, O'Brien RC, Davis JM. Oncoplastic breast reduction: a systematic review of postoperative complications. Plast Reconstr Surg Glob Open 2023; 11 (10) e5355
• 29 Chen Z, Xu Y, Shu J, Xu N. Breast-conserving surgery versus modified radical mastectomy in treatment of early stage breast cancer: a retrospective study of 107 cases. J Cancer Res Ther 2015; 11 (Suppl. 01) C29-C31
• 30 Metz G, Snook K, Sood S. et al. Breast radiotherapy after oncoplastic surgery-a multidisciplinary approach. Cancers (Basel) 2022; 14 (07) 1685
• 31 Jane NE, Zachary G, Mehdi SL, Stephen III JK, Said CA. The radiated breast and autologous reconstruction: benefits and alternatives. Plast Aesthet Res 2024; 11: 22
• 32 Jagsi R, Momoh AO, Qi J. et al. Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction. J Natl Cancer Inst 2018; 110 (02) 157-165
• 33 de Boniface J, Coudé Adam H, Frisell A. et al. Long-term outcomes of implant-based immediate breast reconstruction with and without radiotherapy: a population-based study. Br J Surg 2022; 109 (11) 1107-1115
• 34 De Lorenzi F, Loschi P, Bagnardi V. et al. Oncoplastic breast-conserving surgery for tumors larger than 2 centimeters: is it oncologically safe? A matched-cohort analysis. Ann Surg Oncol 2016; 23 (06) 1852-1859
• 35 Ho W, Stallard S, Doughty J, Mallon E, Romics L. Oncological outcomes and complications after volume replacement oncoplastic breast conservations-the Glasgow experience. Breast Cancer (Auckl) 2016; 10: 223-228
• 36 Joo JH, Ki Y, Kim W. et al. Pattern of local recurrence after mastectomy and reconstruction in breast cancer patients: a systematic review. Gland Surg 2021; 10 (06) 2037-2046
• 37 De la Cruz Ku G, Karamchandani M, Chambergo-Michilot D. et al. Does breast-conserving surgery with radiotherapy have a better survival than mastectomy? A meta-analysis of more than 1,500,000 patients. Ann Surg Oncol 2022; 29 (10) 6163-6188
• 38 Rajan KK, Fairhurst K, Birkbeck B. et al. Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis. BJS Open 2024; 8 (03) zrae040
• 39 Christiansen P, Mele M, Bodilsen A, Rocco N, Zachariae R. Breast-conserving surgery or mastectomy? Impact on survival. Ann Surg Open 2022; 3 (04) e205
• 40 Jonczyk MM, Homsy C, Naber S, Chatterjee A. Examining a decade of racial disparity in partial mastectomy and oncoplastic surgery. J Surg Oncol 2023; 127 (04) 541-549
• 41 Chatterjee A, Offodile IIA, Asban A. et al. A cost-utility analysis comparing oncoplastic breast surgery to standard lumpectomy in large breasted women. Adv Breast Cancer Res 2018; 7: 187-200
• 42 Chatterjee A, Asban A, Jonczyk M, Chen L, Czerniecki B, Fisher CS. A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with free flap reconstruction in the treatment of breast cancer. Am J Surg 2019; 218 (03) 597-604
• 43 Asban A, Homsy C, Chen L, Fisher C, Losken A, Chatterjee A. A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with single stage implant reconstruction in the treatment of breast cancer. Breast 2018; 41: 159-164
• 44 Papp C, Windhofer C, Gruber S. Breast reconstruction with the fasciocutaneous infragluteal free flap (FCI). Ann Plast Surg 2007; 58 (02) 131-136
• 45 Rezaei E, Pouryousef K, Karimi M, Hajebi Khaniki S, Baradaran Sirjani E. Latissimus dorsi musculocutaneous flap inset innovation in breast reconstruction. World J Plast Surg 2019; 8 (03) 394-400